9.17
price down icon5.07%   -0.49
pre-market  Pre-market:  9.29   0.12   +1.31%
loading

Cogent Biosciences Inc Stock (COGT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Research and Development
8.18%
52.70
48.72 50.13 38.87 36.04
Costs And Expenses
7.17%
62.40
58.23 59.58 47.09 43.24
Depreciation and Amortization
0.17%
0.599
0.598 0.581 0.562 0.529
Operating Income/Loss
7.17%
-62.40
-58.23 -59.58 -47.09 -43.24
Nonoperating Income/Loss
5.00%
4.056
3.863 4.198 3.009 4.65
Income/Loss From Continuing Operations Before Tax
7.33%
-58.35
-54.37 -59.58 -44.08 -38.59
Income/Loss From Continuing Operations After Tax
7.33%
-58.35
-54.37 -55.38 -44.08 -38.59
Net Income/Loss
7.33%
-58.35
-54.37 -55.38 -44.08 -38.59
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,878%
94.80
2.3834 86.17 74.75 70.73
Diluted Average Shares
3,878%
94.80
2.3834 86.17 74.75 70.73
Basic Earnings Per Share
1.59%
-0.62
-0.63 -0.64 -0.59 -0.55
Diluted Earnings Per Share
1.59%
-0.62
-0.63 -0.64 -0.59 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):